James Reiffel

  • James Reiffel, MD
    James A. Reiffel, MD, FACC, FAHA, FHRS, FACP
    Affiliation:
    Professor of Clinical Medicine, Dept. of Medicine, Division of Cardiology, Columbia University; and, Attending Physician and co-Director, Electrocardiography Lab, New York Presbyterian Hospital, Columbia University Medical Center Campus
    Biography:

    At the Columbia University Medical Center/New York Presbyterian Hospital, Dr. Reiffel has been actively involved in teaching, research, and clinical practice. He regularly instructs medical students, postgraduate house staff, fellows, and other faculty at the CPMC campus; he has an active practice in consultative clinical cardiology and cardiac arrhythmic disorders, including atrial fibrillation; and he teaches nationally and internationally. In addition, Dr. Reiffel is a member of the Scientific Advisory Committee of the Clinical Research Resource at the Irving Institute for Clinical and Translational Research at CUMC.
    At CPMC, Dr. Reiffel is also a faculty member of the Clinical Electrophysiology Laboratory and Co-Director of the Electrocardography Laboratory. In addition, Dr. Reiffel has been Medical Director of the ECG Core Laboratory of the world reknowned Cardiac Research Foundation.
    Among his other professional activities, Dr. Reiffel is a Fellow of the American College of Physicians, the American College of Cardiology, the American Heart Association; a member of NASPE and of the Vascular Biology Working Group and a diplomate of NASPExAM; and is a peer reviewer for multiple professional journals in medicine and in cardiology.
    Since 1974, Dr. Reiffel has been actively engaged in the management of cardiac arrhythmic disorders. In addition to his patient care activities at CPMC, Dr. Reiffel has been involved in developmental/research studies of electrophysiological techniques, antiarrhythmic pharmaceuticals and devices, anticoagulant therapy for atrial fibrillation, and multiple major multicenter trials including, among others, CAPS, MDPIT, ESVEM, MUSTT, AVID, AFFIRM, AFFECTS, OM-8, ADONIS, ATHENA, RE-LY. Additionally, Dr. Reiffel has over 400 publications related to cardiac dysrhythmias; has been an invited lecturer at many hundreds of programs and institutions world wide; and is a co-author of the antiarrhythmic drug section of the ABIM Clinical Cardiac Electrophysiology Self Assessment Program (EPSAP) and is a co-author of the cardiac arrhythmia section of the ACC self-assessment program for cardiology.
    Dr. Reiffel’s current research interests include the optimum management of patients with atrial fibrillation and flutter; studies in cardiac repolarization as relates to dysrhythmias and gender differences in proarrhythmic risk; and the development of new antiarrhythmic and anticoagulant pharmaceuticals.